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Conclusions. The epidemiological, clinical and mortality 
characteristics of the patients in our series are similar to the 
best published in the literature. The study has identified several 
markers that could be useful at a local level to estimate risk of 
death in septic patients. Studies like this one are necessary to 
make improvements in the Code Sepsis programs.
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RESUMEN
Objetivo. Evaluar el impacto de un programa educativo y 
organizativo llamado Código Sepsis, en los primeros siete me-
ses de su aplicación en un hospital de alta complejidad.
Material y métodos. Se realizó un estudio observacio-
nal durante un período consecutivo de siete meses (Febrero 
2015-Septiembre 2015). Se analizó la relación con la morta-
lidad de los factores de riesgo y los valores analíticos usando 
análisis uni y multivariante.
Resultados. Se incluyeron un total de 237 pacientes. La 
mortalidad intrahospitalaria a los 30 días fue del 24 % y del 
27% a los 60 días. La mortalidad de los pacientes ingresados 
en Unidades de Cuidados Críticos fue del 30%. Se encontraron 
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Objectives. To assess the impact of the first months of 
application of a Code Sepsis in a high complexity hospital, 
analyzing patient´s epidemiological and clinical characteristics 
and prognostic factors.
Materials and methods. A long-term observational 
study was carried out throughout a consecutive period of sev-
en months (February 2015 – September 2015). The relationship 
with mortality of risk factors, and analytic values was analyzed 
using uni- and multivariate analyses. 
Results. A total of 237 patients were included. The 
in-hospital mortality was 24% at 30 days and 27% at 60 days. 
The mortality of patients admitted to Critical Care Units was 
30%. Significant differences were found between the patients 
who died and those who survived in mean levels of creatinine 
(2.30 vs 1.46 mg/dL, p <0.05), lactic acid (6.10 vs 2.62 mmol/L, 
p <0.05) and procalcitonin (23.27 vs 12.73 mg/dL, p <0.05). A 
statistically significant linear trend was found between SOFA 
scale rating and mortality (p<0.05). In the multivariate analysis 
additional independent risk factors associated with death were 
identified: age > 65 years (OR 5.33, p <0.05), lactic acid > 3 
mmol/L (OR 5,85, p <0,05), creatinine > 1,2 mgr /dL (OR 4,54, p 
<0,05) and shock (OR 6,57, P <0,05).
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The Code Sepsis of University Hospital of La Princesa (CSP) 
[3] is a set of clinical, organizational, analytical and microbi-
ological tools that, used together with intensive training and 
cognitive support, has the mission of improving the care of 
septic patients. It prioritizes care and fine-tuning treatment 
and enables simple and efficient clinical work.
The objective of this study was to assess the first months 
of application of a Code Sepsis in a high complexity hospital, 
describing the outcomes and defining the prognosis variables.
MATERIAL AND METHODS 
Intervention: Code Sepsis Princesa 2015. The Code 
Sepsis was launched in February 2015 after 12 meetings held 
throughout 2014 of a multidisciplinary group originally com-
posed of professionals from the departments of Internal Med-
icine, Intensive Care Medicine, Anesthesia and Surgical Critical 
Care, Emergency Medicine, Microbiology, Clinical Analysis, Ad-
mission and Clinical Documentation and General Surgery, and 
later by Nursing, Preventive Medicine, Radiology, and Urology, 
among others, Also, during 2014, prior to Code launch, 14 ses-
sions explaining the Code Sepsis were held in different hospi-
tal departments, and 4 courses of 20 hours were conducted to 
train experts in sepsis for a total of 80 doctors and nurses . The 
Code was disseminated throughout the hospital by means of 
teaching materials in the form of cognitive aids and a hospital 
general session.
The CSP is based on the application of a sequence of co-
herent clinical decisions (figure 1).
When sepsis with organ failure was suspected, a Code 
Sepsis alert was activated in the Electronic Health Record of 
the hospital and sepsis six ( bundle in the first hours) was initi-
ated with the administration of oxygen, antibiotics and fluids, 
and obtaining an analytical profile and cultures. Later when 
the alert was confirmed, and the patient was reevaluated in 
less than three hours to decide whether to continue the treat-
ment at the diagnosis site (emergency department, wards ...) 
or to relocate the patient to a Critical Care Unit due to poor 
evolution.
To facilitate the diagnosis and stratification of patients 
with CSP Alert, the clinicians had available a specific analytical 
tool for sepsis that includes a scalable request, including deter-
minations of complete blood count, including platelets, arterial 
or venous blood gas, including oxygen and CO2 blood pressure 
and lactic acid, biochemical analysis with cretinine, bilirubin 
and procalcitonin, some of them necessary for the calculation 
the Sequential Organ Failure Assessment score (SOFA). 
Blood cultures and other cultures from the suspected fo-
cus of infection are recommended. 
They are prioritized in those patients with CSP alert, using 
rapid detection techniques availablein the hospital like MAL-
DI-TOF or GenomERA, and detection of S. pneumoniae antigen 
by a rapid immunochromatographic assay (ICT).
In order to disseminate knowledge of the CSP, training is 
diferencias significativas entre los pacientes que murieron y 
los que sobrevivieron en sus valores medios de creatinina (2,30 
vs 1,46 mg/dL, p <0,05), ácido láctico (6,10 vs 2,62 mmol/L, p 
<0,05) y procalcitonina (23,27 vs 12,73 mg/dL, p <0,05). Se en-
contró una tendencia lineal estadísticamente significativa en-
tre los valores de la escala SOFA y la mortalidad (p <0,05). En el 
análisis multivariante se identificaron otros factores de riesgo 
independientes asociados con la muerte: edad > 65 años (OR 
5,33, p <0,05), ácido láctico > 3 mmol/L (OR 5,85, p <0,05), 
creatinina > 1,2 mgr/dL (OR 4,54, p <0,05) y el shock (OR 6,57, 
P <0,05).
Conclusiones. La mortalidad en este estudio se encuentra 
dentro de los límites de los ensayos clínicos más recientes de 
sepsis. El estudio ha identificado varios marcadores que po-
drían ser útiles a nivel local para estimar el riesgo en pacientes 
sépticos. Estudios como éste son necesarios para hacer mejoras 
en los programas de Código Sepsis
Palabras clave: Sepsis, código sepsis, mortalidad.
INTRODUCTION
Currently sepsis is a pathology which still shows a high 
mortality rate; the present consensus is that early and ef-
fective treatment of these patients is key to improving their 
healthcare outcomes.
One of the initiatives which have contributed to improve 
care of these patients in Spain is the implementation of Code 
Sepsis programs in hospitals under the auspices of a National 
Code Sepsis Network [1].
These activation codes are the result of applying strategies 
for the coordination of different assistance levels involved in 
time-dependent pathologies. These codes are implemented, with 
the aim of early detecting patients suffering from life-threaten-
ing events (stroke, heart attack...) and triggering the activation 
of measures necessary to improve their prognosis [2].
Figure 1  Flowchart for care of patients with Code 
Sepsis Alert activation
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carried out through specific courses for the hospital physicians 
and nurses experts in sepsis and through general training ses-
sions in the services most often involved.
The following consensus documents, among others, were 
elaborated and placed in the document directory of the hospi-
tal information system:
- CSP protocol: a set of recommendations on suspicion, 
rapid diagnosis, hemodynamic resuscitation and early ad-
ministration of antibiotics, and a guide for the tools and 
protocol summary.
- Antibiotic treatment guide, with high doses adapted to 
septic patient.
- Sample and culture collection protocols.
Design and variables of the study. An analytical obser-
vational prospective study was carried out on all patients with 
an activation of the CSP alert, from February 1, 2015 to Sep-
tember 30, 2015. Only patients with “severe sepsis” (with sepsis 
and organ failure in Sepsis -2 definitions) were included in the 
CSP alert in 2015. “Sepsis” according to the new 2016 defini-
tions (Sepsis-3) is like severe sepsis [4]. There were no exclusion 
criteria. The study included patients with alerts activated any-
where in the hospital: Emergency Department, hospital wards, 
Critical Care Units.
Socio-demographic factors (age, sex), infection risk fac-
tors (acute renal failure, diabetes mellitus, immunosuppres-
sion, antibiotic treatment in the three previous months), and 
other severe risk factors such as admission to critical care units 
and the Sequential Organ Failure Assessment (SOFA) score 
were collected.
Analytical data collection was carried out in three stag-
es: in the first 6 hours after the alert activation, from 6 to 12 
hours and at 12 hours after activation. In each of these stages 
hematocrit, leukocytes, platelets, bilirubin, creatinine, lactic ac-
id and procalcitonin were determined. Also a number of mi-
crobiological culture tests were carried out to identify micro-
organisms.
The fluid management was registered in the first 6h and 
12h. All the antibiotics administered to the patient and the 
need for fluid resuscitation in the first 24 hours were also reg-
istered. 
Outcome variables were overall mortality at 30 and 60 
days and in hospital length of stay.
A prognostic risk variable was created, which combined 
lactic acid ≥3 mmol/L and procalcitonin ≥2 mg/dL in the first 
6 hours. According to this variable, patients were classified as: 
“low risk”, if both indicators were below their threshold; “mod-
erate risk”, if only one of them was above threshold and “high 
risk” if both were above threshold. 
Also another composite variable was created combining 
Shock Index (heart rate/systolic blood pressure) ≥0.8 and lactic 
acid ≥3 mmol/L.
An antibiotic was considered “adequate antibiotic” if it 
was administered according to the hospital guidelines for 
the suspected focus of infection and / or the microorganisms 
isolated in the previous cultures were sensitive and the doses 
applied followed the recommendations of the hospital com-
mission for infections for Code Sepsis. 
Finally, the number of antibiotics administered in the first 
3 hours, between 3 and 6 hours and after 6 hours from the 
activation of the Code Sepsis were also registered
Statistical analysis. For qualitative variables their fre-
quency and percentage were determined. The χ2 test or the 
Fisher nonparametric test was used for their comparison.
For quantitative variables the mean and standard devia-
tion (SD) were calculated. Comparisons were carried out with 
the Student t Test or the nonparametric Mann-Whitney U test.
An explanatory model of mortality with logistic regression 
was constructed, which included all the variables that were 
statistically significant in the univariate analysis, calculating 
the corresponding odds ratio (OR) for each of the variables.
Statistical significance was established as p<0.05. The anal-
yses were carried out with Statistics Software SPSS Version 19 
and Stata / SE, version 13 (Stata Corp, College Station, TX).
The study was approved by the Ethics committee for Clin-
ical Research of La Princesa University Hospital, Registration 
number PI-893.
RESULTS
A total of 237 patients were included. Seventy nine per-
cent (188) of the CSP alerts were activated in the Emergency 
Department and 33% (79) of the total cases needed to be ad-
mitted to the Critical Care Units. The distribution of the clinical 
and epidemiological characteristics, risk factors and severity 
are presented in table 1.
The mean inpatient length of stay was 15 days (SD 28) 
and the mean length of stay in the Critical Care Units was 9 
days (SD 16). The source of the infection was abdominal in 
31.4% (75) of the cases, respiratory in 30.5% (73) and urolog-
ical in 26.4% (63).
Of the 470 cultures taken, 204 were blood cultures (36% 
positives), 133 urine cultures (37% positives), 46 respiratory 
samples (24% positives), 32 stool cultures (37.5% positives), 
22 abdominal fluid samples (68% positives), 15 skin and soft 
parts (66% positives), 8 central line catheters (25% positives) 
and 10 other samples (30% positives). Table 2 shows the more 
frequent isolated microorganisms depending on antibiotic on-
set. Eleven percent (36) of the isolated microorganisms were 
multi-resistant; the most frequent were: carbapenem resistant 
(OXA-48 was the most frequent carbapenemase) and extend-
ed-spectrum β-lactamase producing Klebsiella pneumoniae 
(19%), extended-spectrum β-lactamase producing Escherichia 
coli (16%), and Pseudomonas aeruginosa multidrug-resistant 
(11%).
Changes in biomarker concentrations in the first 24 hours 
of CSP activation were statistically significant. In the case of 
lactic acid, its mean values were 3.47 mmol/L (SD 3.17) in the 
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General data
Age, years (SD) 72 (15)
Sex: Men, n (%) 141 (60)
Hospitalization in the previous 3 months, n (%) 80 (34)
Antibiotics in the previous 3 months, n (%) 73 (31)
Service: emergencies, n (%) 188 (79)
Comorbidity 
Renal insufficiency, n (%) 45 (19)
Diabetes mellitus, n (%) 65 (27)
Immunosuppression, n (%) 51 (21)
Hypertension, n (%) 125 (53)
Ischemic cardiopathology, n (%) 35 (15)
Stroke, n (%) 20 (8)
Neoplasia, n (%) 62 (26)
Clinical data and analyses
HR, bpm (SD) 104 (25)
SBP, mmHg (SD) 107 (28)
Hematocrit, % (SD) 38 (7.5)
Leukocyte /L (SD) 11,916 (12,526)
Platelets /L ( SD) 180,672 (156,527)
Lactic acid, mmol/L ( SD) 3.5 (3.2)
Procalcitonin, mg/dL (SD) 15 (26)
Creatinine, mg/dL (SD) 1.6 (1.1)
Bilirubin, mg/dL (SD) 1.3(1.4)
PaO2/FiO2 (SD) 262 (123)
SAO2/FiO2 (SD) 164 (157)
Severity data
SOFA (SD) 7.8 (4.6)
APACHE (SD) 19.3 (7.9)
Admission Crit. Care U., n (%) 79 (33)
Stay in Crit Care U. in days (SD) 9 (16)
Global stay in days (SD) 15 (28)
Mortality at 30 days, n (%) 56 (24)
Mortality at 60 days, n (%) 63 (27)
Table 1  Characteristics of patients included in 
Code Sepsis
SD: Standard deviation; n: frequency; HR: Heart rate; bpm: beats per minute; SBP: 
Systolic blood pressure; SOFA: Sepsis related Organ Failure Assessment; APACHE: 
Acute Physiology and Chronic Health Evaluation; Crit.Care U.: Critical Care Units
first six hours (0-6 h), 2.99 mmol/L (SD 3.86) (6-12h), 2.02 
mmol/L (SD 1.68) (12-24h) ( p <0.05). Regarding procalcitonin, 
its mean values were the following: 15.04 mg/dL (SD 26.32) 
(0-6h), 23.85 mg/dL (SD 29.97) (6-12h) and 22.53 mg/dL (SD 
33.65) (12-24 h) (p <0.05).
Significant differences were found between the patients 
who died and those who survived in mean levels of creatinine 
(2.30 vs 1.46 mg/dL, p <0.05), lactic acid (6.10 vs 2.62 mmol/L, 
p <0.05) and procalcitonin (23.27 vs 12.73 mg/dL, p <0.05).
With respect to the recommended measures in the ap-
proach to sepsis, 38% (90) of the patients received more than 
2L of crystalloids in the first 6h and 29% (79) more than 4L in 
the first 24h. Thirty five percent of the patients needed vaso-
pressors after resuscitation with fluids. Three hundred-ninety 
antibiotics were administered in total; 56% in the first 3h after 
the activation, 15% between 3 and 6h, and 29% after 6 hours.
The 81% of the antibiotics administered were consid-
ered adequate.
At 30 days the overall hospital mortality was 24% (56). 
At 60 days, mortality was 27% (63); 63% (150) of the patients 
were at home and 10% (24) remained hospitalized or in a 
medical care home. The mortality of the patients admitted to 
the Critical Care Units was 30% (24) and the mortality in hos-
pital wards was 20.3% (32). 
At the time of CSP alert, in those patients admitted to the 
Critical Care Units, the SOFA score was between 0 and 6 in 29 
cases (45%), between 7 and 9 in 19 cases (29%) and above 10 
in 17 cases (26%). We found a statistically significant linear 
tendency between the SOFA rating and mortality at both 30 
days (p<0.05), and 60 days (p<0.05).
Figure 2 shows the percentages of mortality according to 
the SOFA group in those cases where the alert was activated in 
Emergency Department, in those where it was activated in the 
rest of the departments and in the patients who were admit-
ted to the Critical Care Units.
Analyzing the possible relationship of patient comorbidi-
ty variables and clinical-analytical data with mortality, the risk 
factors identified were: age, creatinine, lactic acid, bilirubin, 
and procalcitonin in the first 6h (table 3).
A relationship was found between the patients with a 
Shock Index ≥0.8 and lactic acid ≥3 mmol/L in the first 6h of 
the activation and mortality (p<0.05). Death was 2.5 times 
more likely in these patients.
Analysis of the new prognostic risk variable (lactic acid 
≥3 mmol/L and procalcitonin ≥2 mg/dL) showed that 30% of 
the cases were “low risk”, 42% “moderate risk” and 28% “high 
risk”, with a statistically significant relationship between risk 
and mortality (p<0,05). The risk of dying was 1.5 times higher 
in moderate risk patients and 8 times higher in high risk pa-
tients compared to low risk patients.
A statistically significant relationship was found be-
tween the administration of a single antibiotic or more than 
2 antibiotics and mortality, even stratifying by the SOFA score 
(p<0.05). However, this did not occur with the administration 
of two antibiotics, where the percentage of mortality was 0%. 
The association of total number of antibiotics with mortality 
after 6h showed a linear tendency (p<0.05).
In the multivariate analysis of mortality, some associated fac-
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tors were identified independently: age, lactic acid, creatinine and 
shock (need for vasopressors) (table 4). With the combination of 
these factors, a new variable was created that classified patients ac-
cording to the presence or absence of 1, 2, 3 or 4 of the identified 
factors. Thus, 17 patients (7%) were ≥65 years of age, showed lactic 
acid ≥3 mmol/L, creatinine ≥1.2 mg/dL and need for vasopressors 
(Shock), 13 of which (76.5%) died. A statistically significant rela-
tionship was found between this new variable and mortality, with a 
significant linear trend, where the number of associated risks corre-
lated positively with the risk of mortality (p <0.05).
DISCUSSION
The benefit of activating “Code Sepsis” in a septic patient 
is the speed of reaction in a time-dependent pathology: quick 
diagnosis due to prioritization in the involved departments 
(Microbiology, Clinical Analysis, Radiology) and speed in the 
treatment, prioritizing the need of surgical or interventional 
drainage of the focus as well as the early evaluation by Critical 
Care Units if necessary.
The results of the patients analyzed highlight as opportu-
nities for improvement the need to perform an early identifi-
cation, the need for faster resuscitation and the administration 
of the antibiotic within the first hour of Code activation.
The results of the first few months of application of the 
CSP model are mainly in agreement with the data published 
in the most important recent national [5-7] and international 
studies on sepsis [8-10].
The mean age of the patients in this study is higher than 
that of the patients in the above mentioned publications, while 
their characteristics do not show any other relevant difference. 
The suspected or confirmed sources of infection are also in line 
with those already published. These data make the morbidity 
and mortality outcomes comparable with those of trials and 
publications. 
The death rates in the above men-
tioned publications are between 19 and 
28%, comparable to 24% found in our 
study. It is interesting to highlight the 
high percentage of survivors (63%), 
who are at home at 60 days.
Length of stays in Hospital and 
Critical Care Units are longer in this 
study than in the international ones, 
although they are similar to the few 
national studies published, which may 
not only reflect the higher severity of 
the cases, but also differences in clinical 
practice in different countries. In fact, 
one the most notable circumstances is 
the low number of admissions to the 
Critical Care Units in our sample, 33% 
compared with an average of near-
ly 80% in international studies for the 
same profile of patients [5-7].
Before Antibiotic Onset (N=119) n (%)
Escherichia coli 33 (28)
Klebsiella pneumoniae 13 (11)
Enterococcus faecalis 10 (8)
Staphylococcus epidermidis 8 (7)
Pseudomonas aeruginosa 7 (6)
Streptococcus pneumoniae 7 (6)
Staphylococcus hominis 6 (5)
Rest 35 (29)
During Antibiotic Treatment (N=187) n (%)
Escherichia. coli 45 (24)
Enterococcus faecalis 12 (6)
Enterococcus faecium 11 (6)
Klebsiella pneumoniae 10 (5)
Staphylococcus epidermidis 9 (5)
Candida albicans 8 (4)
Methicillin-resistant S. aureus 7 (4)
Staphylococcus aureus 6 (3)
Rest 76 (42)
Table 2  Isolated microorganisms according to 
antibiotic onset.
N: total number; n: frequency
Figure 2  Percentage of mortality in different SOFA scale groups 
according to the location of Code Sepsis Alert Activation and 
admitted in Critical Care Units.
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The SOFA score, important in the light of the new definitions 
(Sepsis-3), allows us to easily stratify risk and shows a linear corre-
lation with mortality, especially in patients hospitalized in medical 
ward. These patients show the highest SOFA values, indicating a 
delay in the activation of the CSP, which is related to higher death 
rates [17, 18].
In this study, some local risk scales were created by associ-
ating rates and markers, assessing their usefulness to identify 
severity and thus to be used in the location, re-evaluation and 
allocation of resources to these patients, as recommended by cur-
rent precision medicine [19]. In the case of initial lactic acid higher 
than 3mmol/L and procalcitonin higher than 2mg/dL, we find an 
association with mortality in keeping with the literature, especially 
when both are high [20]. This is an interesting scale as it is an ob-
jective biological marker which evaluates infection and perfusion.
The combination of clinical variables and biological mark-
ers also seems very interesting in order to adjust the risk of 
patients in our hospital due to its simplicity of application
According to this study, when the combination of high 
Shock Index and high levels of lactic acid is applied, there is 
The combined use of two antibiotics shows significantly 
better results in these patients compared to using only one or 
a higher number of antibiotics, reflecting the possibility of ad-
justing clinical practice to the new Surviving Sepsis guidelines 
with respect to antibiotic treatment in combination with sepsis 
[11, 12].
Almost 20% of the antibiotics administered were not ad-
equate, detecting an improvement opportunity, for example 
implementing microbiological techniques that accelerate the 
results of sensitivity to the microorganisms that cause sepsis.
With respect to resuscitation with crystalloids, the values 
are lower than those recorded in published studies, with a per-
centage lower than 40% for patients who were administered 2 
litres in the first 6 hours and 4 litres in the first 24 hours. These 
results point to another possibility of improvement [13].
The mean initial values of the biological markers (lactic 
acid, procalcitonin and creatinine) are significantly higher in 
the patients who die with respect to those who survive, re-
flecting its usefulness as objective markers of severity in these 
patients [14-16].
Deaths
OR (CI 95%) p
YES NO
Age > 65 years old, n (%) 50 (29) 6 (9) 4.56 (1.85 – 11.21) 0.001
Sex: Men, n (%) 34 (24) 22 (23) 1.07 (0.60 - 1.97) 0.831
Renal insufficiency, n (%) 13 (29) 43 (22) 1.40 (0.68 – 2.91) 0.358
Diabetes mellitus, n (%) 16 (25) 40 (23) 1.07 (0.55 – 2.09) 0.826
Immunosuppression, n (%) 12 (24) 44 (24) 0.99 (0.47 – 2.06) 0.985
Hypertension, n (%) 30 (24) 26 (23) 1.04 (0.57 – 1.90) 0.887
Ischemic Cardiopathology, n (%) 8 (23) 48 (24) 0.95 (0.40 – 2.23) 0.907
Stroke, n (%) 3 (15) 53 (24) 0.54 (0.15 – 1.93) 0.349
Neoplasia, n (%) 19 (31) 37 (21) 1.65 (0.85 – 3.15) 0.132
Hospitalization in the previous 3 months, n (%) 19 (24) 37 (24) 1.01 (0.53 – 1.90) 0.975
Antibiotic in the previous 3 months, n (%) 13 (18) 43 (26) 0.61 (0.390 – 1.22) 0.162
Need for health care, n (%) 11 (31) 45 (22) 1.60 (0.72 – 3.51) 0.242
Heart rate, bpm (SD) 103 (29) 104 (23) 0.99 (0.98 – 1.01) 0.925
Systolic blood pressure, mmHg (SD) 107 (29) 108 (28) 0.99 (0.99 – 1.00) 0.811
Hematocrit, % (SD) 36 (8.7) 38 (7.1) 0.96 (0.92 – 1.00) 0.066
Leucocytes, thousand/mm3 (SD) 12.31 (10.4) 11.80 (13.1) 1.00 (0.99 – 1.00) 0.793
Platelets, thousand/mm3 (SD) 210.36 (216) 171.81 (133) 1.00 (0.99 – 1.00) 0.117
Bilirubin, mg/dL (SD) 1.81 (2) 1.09 (1)  1.36 (1.04 – 1.78) 0.024
Lactic acid > 3 mmol/L, n (%) 39 (42%) 15 (12%) 1.56 (1.27 – 1.83) 0.000
Procalcitonin > 2 mg/dL, n (%) 22 (29%) 8 (13%) 1.21 (1.02 – 1.44) 0.025
Creatinine >1.2 mg/dL, n (%) 33 (33%) 23 (17%) 1.23 (1.06 – 1.44) 0.004
Table 3  Univariate analysis of association between risk or predictive factors and death.
n: frequency; SD: Standard Deviation; bpm: beats per minute; OR: Odds Ratio; CI: Confidence Interval
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a clear association with mortality. Therefore, this scale may be 
used in our local practice [21, 22].
In the multivariate analysis we have found that age, lactic 
acid, creatinine and shock as factors related to mortality, thus 
emphasizing the importance of adequate resuscitation in the 
outcome of sepsis patients.
The results suggest a very similar situation to the best re-
sults of our environment. The opportunities for improvement 
are clear in resuscitation and antibiotic treatment. Our results 
suggest avoiding excessive administration of antibiotics in the 
first few hours, as is defined in the recommendation for a ra-
tional start of antibiotic treatment [23].
The use of biomarkers and composite local ranges is a 
practice increasingly recommended in the context of precision 
medicine [19] and it is an opportunity for innovation, which 
may help improve patient prognosis and reduce the overuse of 
resources [24, 25].
The fundamental limitation of this study is that it does 
not compare septic patients before and after the implemen-
tation of CSP. At this moment, with the results of this study, 
we have an analysis of the situation at the beginning of the 
project, which gives us an opportunity to analyze its efficiency 
when compared to future stages
Moreover, as a result of new sepsis definitions and the 
campaign “Survive Sepsis 2016”, an updating of CSP was car-
ried out [11]. In this update, measures were included for the 
earlier activation of the alerts and for faster diagnostic tests 
along with the use of local risk scales which combine clinical 
indexes such as the new National Early Warning Score (NEWS 
2) [26] with biomarkers. An evaluation of the 2016 and 2017 
results is currently underway, in order to compare them with 
previous CSP results and implement the necessary measures to 
continue improving.
Sepsis is still an illness which causes death in one in four 
patients affected by sepsis, and thus must continue being a 
priority in the hospital care; Code Sepsis is an opportunity for 
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